Table 1 general preoperative condition of patients
Clinical data | CRF group | control group |
|---|---|---|
Age | 59.90 ± 11.56 | 73.88 ± 8.14 |
RBC(1012/L) | 4.02 ± 0.82 | 4.47 ± 0.47 |
HB(g/L) | 117.49 ± 25.12 | 137.88 ± 16.35 |
Cr (μmol/ L) | 773.06 ± 246.66 | 66.40 ± 11.94 |
Urea (mmol/L) | 26.09 ± 10.66 | 5.43 ± 1.13 |
SBP (mmHg) | 153.93 ± 7.80 | 134.33 ± 10.36 |
DBP (mmHg) | 89.34 ± 8.01 | 77.98 ± 9.67 |
Preoperative IOP (mmHg) | 14.09 ± 2.50 | 13.88 ± 2.67 |
Corneal endothelial cells (mm2) | 2477.78 ± 379.01 | 2623.03 ± 286.15 |
Preoperative BCVA | ||
< 0.05 | 21 (41.2%) | 6 (12%) |
0.05 ~ 0.3 | 23 (45.1%) | 26 (52%) |
0.3 ~ 0.5 | 7 (13.7%) | 9 (18%) |
≥ 0.5 | 0 | 9 (18%) |
Nucleus of lens classification (Emery grading system) | ||
I | 9 (22%) | 2 (5%) |
II | 17 (41.5%) | 12 (30%) |
III | 12 (29.3%) | 19 (47.5%) |
IV | 3 (7.2%) | 7 (17.5%) |
Posterior subcapsular opacification | 14 (34.1%) | 19 (47.5%) |
Ocular complication (eyes) | ||
Caligo corneae/keratoleukoma (Peripheral, d < 2 mm) | 3 | 1 |
Glaucoma (without visual field anomalies) | 2 | 1 |
Obstruction of lacrimal ducts | 2 | 1 |
Exotropia | 1 | 0 |
Systemic complications (patients) | ||
Diabetes | 16 | 5 |
Hypertension | 38 | 7 |
Coronary heart disease | 10 | 4 |
Heart failure | 5 | 1 |
Cerebral infarction | 6 | 0 |